Washington University researchers have developed a chemical compound they say can provide an early diagnosis for Alzheimer’s disease.  Patients with Alzheimer’s disease have normally incurred a significant degree of neurological damage by the time they are diagnosed. A research team says their new chemical compound, known as Fluselenamyl, is capable of detecting amyloid clumps better than current methods approved the by U.S. Food and Drug Administration. {read more here}